Showing 1 - 20 results of 274 for search '(( auc ((values decrease) OR (larger decrease)) ) OR ( _ ((parp decrease) OR (nn decrease)) ))', query time: 0.57s Refine Results
  1. 1
  2. 2

    ROC curve and AUC value of all models. by Tiago de Oliveira Barreto (20485207)

    Published 2024
    “…As for Specificity (82.94%) and ROC-AUC (82.13%), the Multilayer Perceptron with SGD optimizer obtained the highest scores. …”
  3. 3

    Inotodiol decreases clone formation in HCC cells. by Yushuang Xing (20636685)

    Published 2025
    “…In addition, inotodiol showed to induce apoptosis, characterized by an increase in Bax expression, a decrease in Bcl-2, Bcl-XL and MCL1 expression, the initiation of cleaved PARP1 and cleaved caspase 3, and inhibition of the MAPK/ERK pathway. …”
  4. 4
  5. 5
  6. 6
  7. 7

    <b>Supporting data for manuscript</b> "<b>Voluntary locomotion induces an early and remote hemodynamic decrease in the large cerebral veins</b>" by Kira Shaw (18796168)

    Published 2025
    “…The locomotion values (traces and metrics) are in arbitrary units with larger integers representing a greater displacement of the spherical treadmill, the hemodynamic (Hbt) values (traces and metrics) are a percentage change from the normalised baseline (prior to stimulus presentation), and the corresponding time series vector is presented in seconds. …”
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Statistical analysis of the AUC measurement. by Esra Ayan (21156015)

    Published 2025
    “…<p>Analysis indicated that INSv application significantly changed spontaneous calcium activity (IAsp <i>p</i>-value: 0.1290, INSv <i>p</i>-value: 0.0002). The mean AUC decreased in both samples.…”
  14. 14
  15. 15
  16. 16

    PARP9 knockdown promotes apoptosis and DNA damage. by Yating Li (1819822)

    Published 2024
    “…(E) DNA damage in GC cells significantly increased post-PARP9 knockdown as determined by comet assay. (F) The anti-DNA damage capacity of GC cells decreased markedly following reduction of PARP9 expression. …”
  17. 17
  18. 18
  19. 19

    Data Sheet 1_Imaging-based assessment of response to olaparib in platinum-sensitive relapsed ovarian cancer patients.pdf by Maria Delgado-Ortet (8840702)

    Published 2025
    “…In this work, we developed noninvasive imagingbased measurements of spatial and longitudinal heterogeneity in a retrospective analysis of a phase 2 non-randomized study of germline BRCA1/BRCA2 mutated (gBRCAm) ovarian cancer patients treated with combination of PARP inhibitors (PARPi) and immune checkpoint inhibitors (ICIs).…”
  20. 20